Fast Nanoparticle Diffusion in Synovial Fluid May Hold Key to Joint Disease Recovery
University of Florida professors Carlos M. Rinaldi-Ramos and Kyle D. Allen, from the Department of Chemical Engineering and the J. Crayton Pruitt Family Department of Biomedical Engineering, are investigating the application of nanoparticles as diagnostic and therapeutic agents for joint diseases, such as osteoarthritis.
Michele Manuel Named 2021 TMS Brimacombe Medalist
Michele Manuel, Ph.D., professor and chair of the UF Department of Materials Science & Engineering, was recently recognized as a Brimacombe Medalist by The Mineral, Metals & Materials Society (TMS).
How a Robot Developed at UF Could Help First Responders See Through Walls During Rescues
A University of Florida research team is working on a robot dog that has the ability to enter an enclosed space, scan it, and provide humans with a visual of what’s inside, an application that could lessen dangerous situations for first responders.
AavantiBio and Aldevron Announce Strategic Partnership To Develop Next-Generation Gene Therapies for Rare Genetic Diseases
UF startup and UF Innovate | The Hub resident AavantiBio, a gene therapy company focused on transforming the lives of patients with rare genetic diseases, and Aldevron, a global leader in the custom development and manufacture of plasmid DNA, proteins and mRNA for the biotech industry, announced a long-term strategic partnership for the supply of plasmid DNA that will enable AavantiBio to advance its platform of innovative gene transfer therapies.
The One Big Threat When It Comes to Cyber-Security Has Nothing To Do With Software
Though malicious software gets most of the attention when it comes to computer security, the biggest cyber-security threat right now is a hardware problem, says Mark Tehranipoor, director of the Florida Institute for Cybersecurity Research (FICS).
UF Neuroscientists Discover Biomarker With Potential To Aid Parkinson’s Diagnosis
University of Florida neuroscientists have developed a new assay, or test, to detect minute amounts of a protein called tyrosine hydroxylase in blood immune cells of Parkinson’s disease patients, a key finding to aid in the development of a blood test to help diagnose and guide treatment for the neurodegenerative disorder.
Axogen, Inc. Appoints John H. Johnson to Board of Directors
UF startup and UF Innovate | Sid Martin Biotech alum Axogen, Inc., a global leader in developing and marketing innovative surgical solutions for damage or discontinuity to peripheral nerves, announced that John H. Johnson has been appointed to its Board of Directors.
DiaCarta Q&A: Liquid Biopsy for Early Cancer Detection
DiaCarta is initiating a large-scale clinical development program, which will monitor cfDNA levels to determine early treatment outcomes of systemic therapy in all types of stage IV cancer.
Papaya Popularity Prompting Commercial Expansion
University of Florida scientists want to help South Florida farmers increase their economic returns when growing papaya to meet consumer demands and enhance their competitive edge domestically and internationally.
The Key to Life Is Learning | Dr. Ian White Founder of Neobiosis
Dr. Ian White, founder, president and chief scientific officer of UF Innovate | Sid Martin Biotech resident Neobiosis, a CDMO developing new drug applications with the FDA, producing therapeutic regenerative medicine products for human use, is featured on The Huxley Morton Podcast.
